Alvogen Strikes Deals For Pfenex’ Teriparatide

Meanwhile, Pfenex Reports Positive Results In US Equivalence Study

 
• By Aidan Fry
  
Dartboard
Canada and South Korea, along with Israel, are the targets of Alvogen's latest licensing deals for teriparatide • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business